DO YOU NEED FINANCIAL HELP DUE TO A MEDICATION SIDE EFFECT?

0 have signed. Let’s get to 1,500!


U.S. DEPARTMENT OF JUSTICE:  Department of Justice, please require former FDA Commissioner, Dr. Margaret Hamburg, and Renaissance Technologies hedge fund to place all income from May 2009 through March 2015 into a National Patient Injury Compensation Fund.  This income is estimated to be more than $10 billion.

BACKGROUND:  While Dr. Margaret Hamburg was FDA Commissioner from May 2009 through March 2015, her husband, Peter Brown, was an Executive or Co-CEO of Renaissance Technologies hedge fund which held as much as $3 billion of stock in the following major drug and biotech companies.

 

Abbott Labs
ABBVIE
Alexion
Alkermes
Amgen
Astrazeneca
Baxter
Biogen
Bristol Myers Squibb
Celgene
Eli Lilly
Gilead Sciences
GlaxoSmithKline
Hospira
Illumina
Johnson & Johnson/Janssen
Merck
Mylan
Novartis
Novo Nordisk
OraSure
Pfizer
Pharmacyclics
Regeneron
Shire
Spectrum Pharmaceuticals
Stryker
Taro Pharmaceuticals
Teva Pharmaceuticals
Valeant Pharmaceuticals
Vertex
 

CRIMINAL CONFLICT OF INTEREST STATUTE:  Criminal conflict of interest statute 18 U.S.C. § 208, applied to Dr. Hamburg, as FDA Commissioner. Statute 18 U.S.C. § 208: 

“Bars a Federal employee from participating personally and substantially as a Government employee in any particular matter in which the employee has a financial interest.  These restrictions also apply regarding the interests of an employee's spouse . . .”  (FDA website)

DEPARTMENT OF JUSTICE REQUEST:  Please require former FDA Commissioner, Dr. Margaret Hamburg, and Renaissance Technologies hedge fund to place all income from May 2009 through March 2015 into a National Patient Injury Compensation Fund, similar to theNational Vaccine Injury Compensation Program. 

The following individuals would be allowed to submit claims to the National Patient Injury Compensation Fund:

Family members of those who unnecessarily died from May 2009 through March 2015 after consuming a drug made by a company in which Renaissance Technologies held stock while Dr. Hamburg was FDA Commissioner;
 

Individuals who were unnecessarily injured after consuming a drug made by a company in which Renaissance Technologies held stock while Dr. Hamburg was FDA Commissioner from May 2009 through March 2015; and
 

Individuals who did not receive appropriate medical care from May 2009 through March 2015 because a drug made by a company in which Renaissance Technologies held stock while Dr. Hamburg was FDA Commissioner lacked adequate label safety warnings.
 



Today: Terry is counting on you

Terry Aston needs your help with “U.S. DEPARTMENT OF JUSTICE: DO YOU NEED FINANCIAL HELP DUE TO A MEDICATION SIDE EFFECT?”. Join Terry and 1,380 supporters today.